Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yi Lu
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Guangxi Medical University,
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0009-0007-2940-5027
Observed ORCID:
0009-0007-2940-5027
OpenAlex ID:
A5101996562
Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study
2023
·
Jin Zhang
, Xuesong Li
, et al.
·
Cancers
·
16
PDF
Integrating tertiary lymphoid structure–associated genes into computational models to evaluate prognostication and immune infiltration in pancreatic cancer
2024
·
Ying Ma
, Xuesong Li
, et al.
·
Journal of Leukocyte Biology
·
12
Targeting the E2F6-TOP2A-DKK1 axis: a novel therapeutic strategy for EMT-driven hepatocellular carcinoma progression
2026
·
Mindan Xing
, Yi Lu
, et al.
·
Frontiers in Immunology
Glucocorticoid and mitophagy signaling–based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinoma
2026
·
Junjie Yu
, Yantao Jiang
, et al.
·
npj Precision Oncology
PDF
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
2025
·
Xiangqin Zhao
, Xinbo Gao
, et al.
·
Journal of Visualized Experiments
Abstract 729: The role of skp2 in paclitaxel-resistant prostate cancer cells
2015
·
Yeguo Yang
, Qiong Song
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
28
H-index:
2
I10-index:
2
Year
Topic
Type